LOGIN
Low-Molecular Weight Heparin and Aspirin Provide Similar VTE Prevention in Trauma Fracture Patients
September 2020
Low-Molecular Weight Heparin and Aspirin Provide Similar VTE Prevention in Trauma Fracture Patients
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:1
Aspirin versus low-molecular-weight heparin for venous thromboembolism prophylaxis in orthopaedic trauma patients: A patient-centered randomized controlled trial.
PloS one. 2020 Aug 3;15(8):e0235628Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
Three hundred and twenty-nine patients with a traumatic extremity fracture requiring operative treatment where venous thromboembolism prophylaxis was needed were randomized to receive either low-molecular weight heparin (LMWH) or aspirin. The primary outcome of interest included the incidence of mortality, bleeding, venous thromboembolism (VTE), deep surgical site infection, and a combination of t...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.